AB
Abhijit G. Banerjee
Also known as: AG Banerjee, A. Banerjee
CG BIOMED LLP, Genomic Bio-Medicine Research and Incubation, Chhattisgarh (CGBMRI), Indian Institute of Technology Kharagpur, Banaras Hindu University, Ayush & Health Sciences University Chhattisgarh
About
Senior R&D and Strategic planning executive with 30+ years of experience driving translational science, biologics innovation, and product-focused research strategies across oncology and chronic inflammatory diseases. Mentors startups and educational initiatives in Medical Biotechnology for last 16 years.
Employment
-
CG BIOMED LLP CSO2026 - Present
-
Genomic Bio-Medicine Research and Incubation, Chhattisgarh (CGBMRI) Executive Director - Research, Innovations & Incubation, Private Foundation2012 - Present
-
Ayush & Health Sciences University Chhattisgarh Associate Professor (sabbatical year)2010 - 2010
-
University of Manitoba Adjunct Professor2009 - 2012
-
University of Manitoba Faculty of Health Sciences Assistant Professor & Director, Molecular Oncology & Medicine Labs2004 - 2009
-
University of Nebraska Medical Center College of Medicine Post-doctoral Research Associate (J-1Visiting Scientist)2001 - 2004
-
Daiichi Sankyo Kabushiki Kaisha Senior Research Scientist (R&D, Mgr- grade3)1999 - 2001
-
Tata Memorial Centre Scientific Officer-D (PB-3)1997 - 1999
-
Torrent Research and Development Centre Scientist-1 (Manager-R&D)1994 - 1997
Education
-
Indian Institute of Technology Kharagpur PhD1989 - 1995
-
Banaras Hindu University Masters1987 - 1989
Projects & Funding
Projects & funding information is unavailable.
Publications (46)
- <p>Selection of Ethyl Acetate for Fractionation and Enrichment of Semi-Polar Phytochemicals from Medicinal Plants</p> <p><br></p> Save
- Regulating Epithelial-Mesenchymal Transition and Cancer Metastasis: The Multifaceted Role of Emodin Save
- Therapeutic Potential of Cajanus cajan-Derived Stilbenoids and Flavonoids: From Crop Wastage to Cancer Therapeutics Save
- Synergistic Inhibition of MARCKS-driven Oncogenic Signaling in HNSCC by Emodin and Inositol Hexaphosphate (IP6): A Systems Biology and AI-enhanced Study Save
- Polypharmacological Prospects and Therapeutic Indications of Swertiamarin Scaffolds for Natural Drug Discovery Save
- Oral Microbiome Dysbiosis, MARCKS-Dependent Macrophage Signaling, and Tumor-Associated Macrophages: Emerging Links Between Periodontitis, Systemic Disease, and Carcinogenesis Save
- Glycosaminoglycans and Proteoglycans in Oral Cancer: From Pathobiology to Therapeutic Opportunities Save
- Gene Networks in OSCC Across the Logical Progression Cascade, With Neuro-Psychiatric Outcomes: A TCGA Based Network Biology Paradigm Save
- From Pathogens to Tumors: Reframing LAMP–qPCR Translatability as a Unified Diagnostic Paradigm Across Infectious Disease and Oncology <div> - A Perspective </div> Save
- FRZB Prognostic Value in Severe Oral Dysplasia and Head and Neck Squamous Cell Carcinoma: A Computational Genomics Study Save